近期事件 2月5日，国家医保局发布《关于加快医疗保障领域场景培育和开放支持新场景大规模应用的通知》，政 策聚焦医保服务创新，推动IVD行业向"检测+AI+服务"模式转型，可能为爱威科技等体外诊断企业带来 新市场机会。此外，公司近期在投资者互动中表示，已通过新设子公司(如湖南爱威检验、北京爱微智 检)拓展下游检验服务，布局"设备+服务"双轮驱动战略。 经济观察网近7天，爱威科技(688067)股价呈现波动上涨态势，区间累计涨幅为2.69%，振幅达6.16%。 具体来看，2月9日股价上涨2.07%，收盘报29.05元，主力资金净流入328.91万元；2月10日股价回调 0.96%，但主力资金仍净流入380.28万元；截至2月11日最新数据，股价报29.00元，当日涨幅0.80%。资 金流向显示，近期主力资金整体呈净流入状态，反映市场关注度较高。 机构观点 湘财证券2月8日发布的体外诊断周报指出，尽管当周板块下跌1.28%，但爱威科技表现居前(周涨幅 +1.4%)。政策驱动下，IVD行业有望加速与AI、医保支付融合，长期利好具备技术和服务整合能力的企 业。 以上内容基于公开资料整理，不构成投资建议。 ...

Investment Rating - The report maintains an "Overweight" rating for the in vitro diagnostics (IVD) industry [7]. Core Views - The recent policy from the National Healthcare Security Administration aims to transform the role of healthcare insurance from a payer to an innovator, significantly impacting the IVD industry by promoting solutions that integrate "testing + AI + services" [5][51]. - The domestic IVD industry is currently in a bottoming phase, with a strong focus on the growth potential of immunodiagnostics, particularly in chemiluminescence and molecular diagnostics such as PCR [5][51]. - The report highlights that the biochemical diagnostics sector in China has largely completed its localization process, reducing reliance on foreign technologies [5]. Summary by Sections Industry Performance - The pharmaceutical and biological sector rose by 0.14%, ranking 15th among 31 primary industries, while the IVD sector fell by 1.28% [2][10]. - The IVD sector's current PE (ttm) is 39.37X, with a PB (lf) of 1.80X, showing a slight decrease from the previous week [4][31]. Company Performance - Notable performers in the medical services sector include SAIKOSHI (+14.5%), Ruiang Gene (+3.1%), and Rendu Bio (+2.6%), while underperformers include Cap Bio (-6.8%) and Hotgen Bio (-6.4%) [3][26]. - The report suggests focusing on companies like YHLO Biotech and Shengxiang Bio in the immunodiagnostics and molecular diagnostics fields due to their growth potential [5][51]. Market Trends - The report indicates that the IVD industry is experiencing a shift towards integrating new technologies and payment methods, driven by recent policy changes [5][51]. - The overall IVD market is expected to continue its steady growth, with significant opportunities arising from the integration of AI and innovative products [5][51].